Bipolar Disorder
📧 Sign up to get email alerts when something new happens for Bipolar Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Clinical Trial of Felbamate for Treatment-Resistant Bipolar Depression [Phase 2]
A Phase 2 clinical trial evaluating felbamate for treatment-resistant bipolar depression has completed.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Effects of Drugs on Cerebral Blood Flow in Patients With Mood Disorders
A completed National Institute of Mental Health–sponsored trial examined how certain drugs affect cerebral blood flow in people with mood di…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Evaluation of Patients With Rapid Cycling Bipolar Disorder (RCBD)
A National Institute of Mental Health-sponsored clinical trial evaluating patients with rapid cycling bipolar disorder has completed.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Clozapine for Treatment-Resistant Mania [Phase 2]
This entry notes the completion of a Phase 2 clinical trial evaluating clozapine for treatment-resistant mania in bipolar disorder, sponsore…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Effects of Sex Hormones on Circadian Rhythm in Men and Women
A completed clinical trial from the National Institute of Mental Health evaluating how sex hormones affect circadian rhythm in men and women…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: The Evaluation and Follow-up of Patients With Bipolar Disorder
A completed clinical trial update describing the evaluation and follow-up of patients with Bipolar Disorder.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: The Treatment of Children and Adolescents With Treatment-Resistant Depression
This clinical trial update reports on treatment-resistant depression in children and adolescents with Bipolar Disorder. The study is sponsor…
-
CLINICAL_TRIALS research · 2008-03-04Clinical Trial Update: Genetic Aspects of Neurologic and Psychiatric Disorders
A National Institute of Mental Health clinical trial update reports completed research on the genetic aspects of several neurologic and psyc…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Study of the Psychological Development of Children of Parents With and Without Affective Disorders
This completed clinical trial, sponsored by the National Institute of Mental Health, studied the psychological development of children of pa…
-
FDA approval · 2008-02-11FDA Approved: CARBAMAZEPINE — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved Torrent Pharmaceuticals Limited's supplemental application for carbamazepine, a generic anticonvulsant. The approval updates th…
-
FDA approval · 2008-02-11FDA Approved: CARBAMAZEPINE — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for a generic Carbamazepine product from Torrent Pharmaceuticals Limited (ANDA 077272).
-
FDA approval · 2008-01-11FDA Approved: CARBAMAZEPINE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for carbamazepine submitted by Chartwell RX, LLC for an existing generic product.
-
CLINICAL_TRIALS trial_result · 2008-01-04Clinical Trial Update: A Randomized Control Trial Comparing Quetiapine to Risperidone in Bipolar Disorder With Stimulant Dependence [NA]
A randomized trial comparing quetiapine to risperidone in individuals with bipolar disorder and stimulant dependence has completed.
-
CLINICAL_TRIALS trial_result · 2008-01-04Clinical Trial Update: Improving Care for Patients With Bipolar Disorder [NA]
This update reports the completion of a clinical trial aimed at improving care for patients with bipolar disorder, sponsored by the Universi…
-
FDA approval · 2007-12-26FDA Approved: LITHIUM CARBONATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for lithium carbonate submitted by Hikma Pharmaceuticals USA Inc.
-
FDA approval · 2007-12-26FDA Approved: CARBAMAZEPINE — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for carbamazepine from Torrent Pharmaceuticals Limited.
-
FDA approval · 2007-12-19FDA Approved: EQUETRO — Supplemental Application (Validus Pharmaceuticals LLC)
FDA approved a supplemental application for EQUETRO (carbamazepine) submitted by Validus Pharmaceuticals LLC.
-
CLINICAL_TRIALS trial_result · 2007-12-18Clinical Trial Update: Efficacy and Safety of Quetiapine Compared With Valproate in the Treatment of Patients With Bipolar Disorder and Rapid Cycling [Phase 3]
The document reports a Phase 3 trial comparing quetiapine with valproate for bipolar disorder with rapid cycling that has completed.
-
FDA approval · 2007-12-17FDA Approved: CARBAMAZEPINE — Supplemental Application (Torrent Pharmaceuticals Limited)
The FDA approved Torrent Pharmaceuticals Limited's supplemental application for Carbamazepine, a generic antiepileptic. The action updates t…
-
CLINICAL_TRIALS trial_result · 2007-12-14Clinical Trial Update: Depakote ER Therapy for Mania Comorbid With Substance Abuse [Phase 4]
Phase 4 clinical trial update on Depakote ER for mania in bipolar disorder with comorbid substance use disorder; the study status is complet…
-
CLINICAL_TRIALS trial_result · 2007-12-14Clinical Trial Update: Open Label Study of Lithium Plus Extended-Release Carbamazepine (ERC-CBZ) for Rapid Cycling Bipolar Disorder [Phase 4]
Open-label Phase 4 study evaluating lithium in combination with extended-release carbamazepine for rapid cycling bipolar disorder; the updat…
-
FDA approval · 2007-12-11FDA Approved: TEGRETOL XR — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for Tegretol XR (carbamazepine) from Novartis Pharmaceuticals Corporation.
-
FDA approval · 2007-12-11FDA Approved: TEGRETOL — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for Tegretol (carbamazepine) filed by Novartis Pharmaceuticals Corporation.
-
FDA label_change · 2007-12-11FDA Approved: TEGRETOL — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for Tegretol (carbamazepine) filed by Novartis Pharmaceuticals Corporation. The update concerns …
-
CLINICAL_TRIALS trial_result · 2007-12-06Clinical Trial Update: Behavioral Processes Underlying Reward Processing in Depression
A completed ClinicalTrials.gov study by Affective Neuroscience Laboratory examined reward processing in depression, including major depressi…